← Compounds

Cortexin

peptide · headlineResearch use only

Modulates expression of neurotrophic factors such as BDNF and NGF

Summary

Cortexin is a peptide-based neurobioregulator derived from bovine brain extracts, widely used in Eastern Europe for cognitive decline, stroke recovery, and neurodevelopmental disorders. It exerts neuroprotective, metabolic, and anti-inflammatory effects, enhancing memory, learning, and synaptic repair.

How it works

  • Modulates expression of neurotrophic factors such as BDNF and NGF
  • Improves metabolic support for neurons by enhancing cerebral glucose and oxygen use
  • Reduces excitotoxicity and regulates glutamate and GABA balance
  • Exerts antioxidant and anti-inflammatory effects in the CNS

Dosing

  • unit: mg
    low dose: 5
    frequency: Once daily for 10 days per cycle
    high dose: 20
    standard dose: 10
    administration route: Intramuscular (IM)

Cycling

  • Inject 10 mg daily for 10 consecutive days. Repeat cycle every 3–6 months for chronic neurological support or cognitive maintenance.

Side effects

common: ["Mild headache","Injection site irritation"]
warnings: ["May cause overstimulation or restlessness in sensitive individuals"]
long term: ["No significant adverse effects reported in existing clinical studies"]

Chemistry & PK

sequence: Derived from polypeptide fractions of bovine cerebral cortex
half life: Not clearly defined; sustained biological activity observed
degradation: Hydrolyzed by tissue peptidases
molecular formula: Varied (Bioregulator Peptide Complex)
tissue specificity: High brain tissue specificity due to peptide fraction targeting

Verified citations

3 · PubMed-checked
  • Peptide drug cortexin inhibits brain caspase-8.mechanismPMID 28251948
  • An open clinical trial of cortexin in treatment of brain ischemia.clinicalPMID 25403301
  • Cortexin. Molecular mechanisms and targets of neuroprotective activity.reviewPMID 26356623

Used for

No condition evidence rows yet.

Legal / compounding

Research use only

Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.